A small peptide promotes EphA2 kinase-dependent signaling by stabilizing EphA2 dimers

This work is a proof-of-principle demonstration that EphA2 homointeractions in the plasma membrane can be pharmacologically modulated to decrease the pro-tumorigenic signaling of the receptor.